AM-x Synthetic Cannabinoids Cannabinoid Research

AM-x Synthetic Cannabinoids Research Dashboard

180

Primary Studies

191

Related Studies

371

Total Studies

Clinical Studies

0

Clinical Meta-analyses

0

Double-blind Clinical Trials

1

Clinical Trials

Pre-Clinical Studies

42

Meta-analyses/Reviews

112

Animal Studies

24

Laboratory Studies

What am I missing as a non-subscriber?

To see a full dashboard with study details and filtering, go to our DEMO page.

As a subscriber, you will be able to access dashboard insights including chemotype overviews and dosing summaries for medical conditions and organ system and receptor breakdowns for cannabinoid and terpene searches. Study lists present important guidance including dosing and chemotype information with the ability to drill down to the published material. And all outputs are fully filterable, to help find just the information you need. Stay up-to-date with the science of cannabis and the endocannabinoid system with CannaKeys.

CannaKeys has 371 studies associated with AM-x Synthetic Cannabinoids.

Here is a small sampling of AM-x Synthetic Cannabinoids studies by title:


Ready to become a subscriber? Go to our PRICING page. Want to learn more about Endocannabinoid Medicine? Buy a book.

Endocannabinoid Medicine 12 Keys to Deeper Healing paperback book published by CannaKeys

Endocannabinoid Medicine: 12 Keys to Deeper Healing

A clear, science-based guide to working with the endocannabinoid system for whole-body balance.

Buy Book
Cannabis for Chronic Pain Relief A dual Guide for Clinicians and Patients - a paperback book published by CannaKeys

Cannabis for Chronic Pain Relief: A Dual Guide for Patients and Clinicians

A practical, evidence-based guide to using cannabis and cannabinoids for chronic pain.

Buy Book

Select New Cannabinoid

Filter Cannabinoid

Members can filter by the following criteria:

  • Study Type
  • Organ Systems
  • Terpenes
  • Receptors
  • Ligands
  • Study Result
  • Year of Publication

Overview - AM-x Synthetic Cannabinoids

Description of AM-x Synthetic Cannabinoids

The AM class of synthetic cannabinoids were largely developed, characterized, and subsequently named after Alexandros Makriyannis, a professor of biochemistry at Northeastern University in Boston.


The AM family of cannabinoids consists of over 40 individual members that produce diverse and varying effects via modulating various components of the ECS. Some members are also analogues with compound classified under a different heading such as for example AM-678 aka as JWH-018.


Here we focus on AM-251.


Other examples you will find in the primary study listings include is AM281 (CB1 antagonist), AM-404, AM-630 (CB2 antagonist), AM-1241 (CB2 agonist), AM-1248, AM-4113 (CB1 antagonist), AM-7410 (CB1 agonist), AM-5206 (FAAH inhibitor)

Other Names:

AM Family Synthetic Cannabinoids

AM-251


Molecular Formula: C22H21Cl2IN4O


IUPAC Name: 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-piperidin-1-ylpyrazole-3-carboxamide


Source–PubChem

AM-x Synthetic Cannabinoids Properties and Effects

Only Members can view Properties and Effects information. See DEMO page.

AM-x Synthetic Cannabinoids Receptor Binding

Only Members can view Receptor Binding information. See DEMO page.

Disclaimer
Information on this site is provided for informational purposes only and is not meant to substitute for the advice provided by your own licensed physician or other medical professional. You should not use the information contained herein for diagnosing or treating a health problem or disease. If using a product, you should read carefully all product packaging. If you have or suspect that you have a medical problem, promptly contact your health care provider.

Information on this site is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your physician, nutritionally oriented health care practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications.